Lupin Turns Up Heat With Bausch Brands Acquisition, Perforomist Generic Launch
Generic Spiriva Launch Awaited, Seeks Xopenex Gains
Two acquisitions of brands in as many months, Lupin has stepped up its game in the Americas. A buyout of nine established Bausch Health brands follows rights to two from Sunovion. While it awaits news on generic(g) Spiriva, the launch of gPerforomist will help expand Lupin’s respiratory franchise
